📢 Visit SeeTreat at ESTRO2026!
ESTRO2026


Visit Us:

15 - 18 May, Booth C13:71

Stockholmsmässan, Mässvägen 1, 125 30 Älvsjö, Sweden

SeeTreat will be at ESTRO 2026 in Stockholm at Booth C13:71, sharing our vision for the future of same-day adaptive re-planning.

Drop by the booth for a coffee ☕ and a conversation about what’s next for adaptive radiotherapy.

ESTRO2026 Booth
SeeTreat's ART.1 is now CE Marked under EU MDR - Bringing Adaptive Radiotherapy to Every Clinic 
Michelle JoinerMichelle Joiner

March 2, 2026

SeeTreat's ART.1 is now CE Marked under EU MDR - Bringing Adaptive Radiotherapy to Every Clinic 

SeeTreat announced today that its offline adaptive radiotherapy software, ART.1, has received CE Mark certification under the European Union Medical Device Regulation and is now available for clinical use across the European Union.

Read more

Abstract at ESTRO 2026

Track: RTT Topic: Innovations for photon and protons delivery

Quantifying the Dosimetric Impact of Daily Anatomical Variations in Breast Radiotherapy Using Automated CBCT-Based Dose Reconstruction

Abstract Illustration
Portrait of Shivani Kumar

Dr Shivani Kumar will be presenting her abstract Quantifying the Dosimetric Impact of Daily Anatomical Variations in Breast Radiotherapy Using Automated CBCT-Based Dose Reconstruction on May 17, 2026


🎙️How do we make the right treatment decision easier for every cancer patient - while also reducing long-term treatment toxicity?

SeeTreat CEO Dr Trang Nguyen shares her perspective on clinical innovation, software adoption, and the future of personalised radiation therapy in this ANDHealth Unfiltered conversation.


Request Whitepapers

Cover image